ERBB2 and cancer: Therefore, our data are in line with these studies, as we showed that high post-treatment vinculin expression, in both ER+ and HER2+ cancer cells (Figures 7A, B, 8A, B), correlates with decreased potential for detachment and, therefore, migration upon ECM from the yielded evidence of detachment, spreading and cell stiffness.